OBJECTIVE: Studies supporting the association of increased maternal body mass index (BMI) and adverse pregnancy outcomes fail to quantify risks of individual BMI classes. The purposes of this study were to assess for significant trends as BMI increased and to examine associations between each pre-pregnancy BMI class and obstetric complications. STUDY DESIGN: This IRB-approved retrospective cohort study analyzed pregnant women ages 18-50 years with singleton gestations and available pre-pregnancy BMI who delivered at Geisinger from 1/ 1/2004-12/31/2017. We excluded pregnancies complicated by multifetal gestations, chronic hypertension, or preexisting diabetes mellitus. Patients were stratified by pre-pregnancy BMI according to World Health Organization classifications. Maternal outcomes included gestational hypertension (GHTN), preeclampsia, gestational diabetes mellitus (GDM), preterm delivery (PTD), preterm pre-labor rupture of membranes (PPROM), induction of labor (IOL), mode of delivery, estimated blood loss (EBL), and operative time. Neonatal outcomes included birthweight (BW), hypoglycemia and neonatal intensive care unit (NICU) admission. Logistic regression was used to compare groups and to calculate the test of trend for binary outcomes. ANOVA was used for continuous outcomes. RESULTS: A total of 27,523 women were included for maternal outcomes. Of these, 945 (3.4%) were underweight (UW), 11,328 (41.2%) normal weight (NW), 6797 (24.7%) overweight (OW), 4271 (15.5%) Class I, 2418 (8.8%) class II, and 1764 (6.4%) class III. There were 26,648 pregnancy episodes with neonatal data linked to maternal: these were used for neonatal outcomes. We adjusted for age, race, parity, and tobacco use: GHTN, preeclampsia, GDM, IOL, vaginal delivery, EBL, operative time, neonatal BW, hypoglycemia and NICU admission significantly increased as BMI increased (Table). UW women had higher PTD, PPROM, EBL, NICU admissions, and lower neonatal BW when compared to NW women. OW and all obesity classes had higher rates of GHTN, preeclampsia, GDM, IOL, vaginal delivery, vaginal delivery, EBL, longer operative time, and higher neonatal BW when compared to NW. CONCLUSION: Our results provide specific delineation of risks associated with specific pre-pregnancy BMI classes. GHTN, preeclampsia, GDM, vaginal delivery, EBL, and operative time increase as BMI class increases. Neonatal BW, hypoglycemia and NICU admissions also increase as BMI class increases. We performed a retrospective cohort study of singleton, non-anomalous pregnancies comparing the rates of largefor-gestational age (LGA) infants to women with an early hemoglobin A 1C (HbA 1C ; drawn <20 weeks gestation) of <5.7% (normal) to 5.7-6.4% (pre-diabetes) who delivered at Oregon Health & Science University from 2012-2014. Chi squared analysis was performed to compare rates of LGA, shoulder dystocia, gestational diabetes, preeclampsia, and cesarean delivery in women with a normal HbA1C (<5.7%) versus pre-diabetic HbA1C (5.7-6.4%). Multivariate logistic regression was used to determine the strength of association between LGA infants and HbA 1C , adjusting for body mass index, maternal weight gain, gestational diabetes, preeclampsia, chronic hypertension and tobacco use. RESULTS: Of the 643 patients in whom HbA 1C was obtained <20 weeks gestation, women with HbA 1C in the pre-diabetes range had significantly higher rates of LGA infants (21.7 vs 10.2%; p<0.001), gestational diabetes (GDM; 59.4 vs 20.8%, p< 0.001), and shoulder dystocia (4.5 vs 1.7%, p<0.050) compared to women with normalrange HbA 1C . HbA 1C in the pre-diabetic range was significantly associated with a 70% increased risk of LGA (OR 2.4 [95% CI 1.4-4.2]) that remained statistically significant after adjusting for relevant confounders (aOR 2.04 [95% CI 1.11-3.73]) including GDM. Incidence of cesarean delivery and preeclampsia were not significantly different between groups. CONCLUSION: Maternal HbA 1C of 5.7-6.4% <20 weeks gestation is associated with an increase in LGA infants independent of recognized risk factors for LGA such as obesity and GDM. Our data suggests that an elevated HbA 1C prior to 20 weeks gestation may be a marker for dysmetabolism, beyond insulin resistance. Future studies to further characterize and develop early interventions to reduce rates of LGA in this population are necessary to improve perinatal outcomes.
OBJECTIVE:
To evaluate the rate of large-for-gestational age infants delivered by women with an early normal versus pre-diabetic range hemoglobin A 1C . STUDY DESIGN: We performed a retrospective cohort study of singleton, non-anomalous pregnancies comparing the rates of largefor-gestational age (LGA) infants to women with an early hemoglobin A 1C (HbA 1C ; drawn <20 weeks gestation) of <5.7% (normal) to 5.7-6.4% (pre-diabetes) who delivered at Oregon Health & Science University from 2012-2014. Chi squared analysis was performed to compare rates of LGA, shoulder dystocia, gestational diabetes, preeclampsia, and cesarean delivery in women with a normal HbA1C (<5.7%) versus pre-diabetic HbA1C (5.7-6.4%). Multivariate logistic regression was used to determine the strength of association between LGA infants and HbA 1C , adjusting for body mass index, maternal weight gain, gestational diabetes, preeclampsia, chronic hypertension and tobacco use. RESULTS: Of the 643 patients in whom HbA 1C was obtained <20 weeks gestation, women with HbA 1C in the pre-diabetes range had significantly higher rates of LGA infants (21.7 vs 10.2%; p<0.001), gestational diabetes (GDM; 59.4 vs 20.8%, p< 0.001), and shoulder dystocia (4.5 vs 1.7%, p<0.050) compared to women with normalrange HbA 1C . HbA 1C in the pre-diabetic range was significantly associated with a 70% increased risk of LGA (OR 2.4 [95% CI 1.4-4.2]) that remained statistically significant after adjusting for relevant confounders (aOR 2.04 [95% CI 1.11-3.73]) including GDM. Incidence of cesarean delivery and preeclampsia were not significantly different between groups. CONCLUSION: Maternal HbA 1C of 5.7-6.4% <20 weeks gestation is associated with an increase in LGA infants independent of recognized risk factors for LGA such as obesity and GDM. Our data suggests that an elevated HbA 1C prior to 20 weeks gestation may be a marker for dysmetabolism, beyond insulin resistance. Future studies to further characterize and develop early interventions to reduce rates of LGA in this population are necessary to improve perinatal outcomes.
Poster Session IV OBJECTIVE: Stillbirth is associated with an increased rate of maternal blood transfusion. However, the association between stillbirth and other conditions within the Centers for Disease Control (CDC)'s severe maternal morbidity (SMM) composite remains unexamined. We aimed to determine whether stillbirth was associated with higher odds of having conditions within the SMM composite compared to livebirth. STUDY DESIGN: This retrospective cohort study used the Florida State Inpatient Database. The first delivery of all Florida residents aged 13 to 55 years old from 2005 to 2014 was included. ICD-9-CM diagnosis codes identified type of birth (stillbirth 23 weeks versus term, singleton liveborn) and presence of SMM during delivery hospitalization. The primary outcome was the CDC's composite of SMM, which includes 21 conditions ranging from acute myocardial infarction or blood transfusion to ventilation. Secondary outcomes included a SMM composite without blood transfusion and individual morbidities within the SMM composite. We compared outcomes after stillbirth 23 weeks to those after term, liveborn singletons using multivariable logistic regression to adjust for mode of delivery and maternal age, race, health insurance type, and income quartile. RESULTS: 9678 women with stillbirth and 1,356,107 with livebirth were included. During delivery, 7.6% of women with stillbirth had SMM including blood transfusion; the odds were more than 6.5 times higher compared to liveborn (adjusted odds ratio (aOR) 6.66 (95% confidence interval (CI) 6.16 e 7.21). Excluding transfusion, 2.5% of women with stillbirth had SMM; the odds were more than 5.5 times higher compared to women with livebirth (aOR 5.55 (95% CI 4.87 e 6.33)). With the exception of severe anesthetic complications, each condition within the composite had significantly higher odds during delivery hospitalization of stillbirth versus term livebirth, particularly for sepsis (0.9% vs 0.06%; aOR 18.95 (95%CI 15.10 e 23.80)), shock (0.5% vs 0.04%; aOR 16.39 (95% CI 11.94 e 22.48)), and acute renal failure (1.1% vs 0.09%; aOR 15.54 (95% CI 12.59 e 19.19)). CONCLUSION: Though blood transfusion is the most common SMM associated with stillbirth, these data suggest nearly all of the conditions within the CDC's SMM composite are significantly more common among women with stillbirth vs. livebirth. Providers and hospitals who deliver women with stillbirth 23 weeks must be prepared to manage all SMM, not only provide blood transfusion.
814 Racial disparities in maternal critical care -are there racial differences in level of care?
Adina R. Kern-Goldberger, Alexander M. Friedman, Leslie Moroz, Cynthia Gyamfi-Bannerman Columbia University Irving Medical Center, New York, NY OBJECTIVE: Obstetric care in the US is complicated by marked racial and ethnic disparities in maternal obstetric outcomes, including severe morbidity and mortality, which are not explained by underlying differences in patient characteristics. Understanding differences in care delivery related to clinical acuity across different racial groups can help elucidate the source of these disparities. This study examined the association of maternal race with utilization of critical care interventions. STUDY DESIGN: This is a secondary analysis of a multicenter observational study of delivery after prior uterine scar. All women with a known delivery date were included. The primary outcome measure, a composite of critical care interventions (CCI) at delivery or postpartum that included mechanical ventilation, central and arterial line placement, and ICU admission were compared by racial/ethnic group enon-Hispanic white, non-Hispanic black, Hispanic, Asian, and Native American. We evaluated differences in utilization of critical care with a multivariable regression model accounting for selected characteristics present at admission for delivery, including maternal age, BMI, co-morbidities, parity, and plurality. We then compared the frequency of CCIs by maternal co-morbidity, specifically heart disease, renal disease, and chronic hypertension, to ascertain the level of care provided to women of different race with specific baseline co-morbidities. RESULTS: 73,096 of 73,257 women in the parent trial met inclusion criteria, of whom 505 (0.7%) received a CCI and 3337 (4.6%) had a significant co-morbidity (1.2% heart disease, 0.8% renal disease, 2.5% chronic hypertension). For the same disease type, the distribution of critical care interventions remained higher for black and Hispanic patients (Figure 1) . However, in the adjusted model, there
